Otsuka Pharmaceutical Development & Commercialization

Last update: November 14, 2019

Pharmaceuticals
United States (USA) Its 15 main executives

Recent executive movements at Otsuka Pharmaceutical Development & Commercialization

William Carson who is President & Chief Executive Officer, will become Chairman of the Board on Jan. 1, 2020  (news posted on November 14 2019).

Create an alert
to follow the executive moves at Otsuka Pharmaceutical Development & Commercialization.

Latest M&A news in Pharmaceuticals.

KKR has acquired J B Chemicals & Pharmaceuticals (posted on Jul 7, 2020).
La Jolla Pharmaceutical has announced the acquisition of Tetraphase Pharmaceuticals (posted on Jun 24, 2020).
Melinta Therapeutics has announced the acquisition of Tetraphase Pharmaceuticals (posted on Jun 5, 2020).

Latest news about Otsuka Pharmaceutical Development & Commercialization

Otsuka Pharmaceutical Development & Commercialization on Wikipedia, Google News & Yahoo Finance

Otsuka Pharmaceutical Development & Commercialization on LinkedIn, Twitter & YouTube

Otsuka Pharmaceutical Development & Commercialization has 2,010 competitors including Johnson & Johnson (United States (USA)), Sanofi (France) and Roche (Switzerland). Otsuka Pharmaceutical Development & Commercialization is owned by Otsuka Pharmaceutical.

The most constantly updated executive directory.

Companies

Companies

Learn about your clients' org charts. Understand their industries and their competitors.

Executives

Executives

View the executives' biographies. Contact the executives through our email platform.

Alerts

Alerts

Select key words to follow your clients. Receive alerts when executive movements happen.

Customers

Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.